Search Within

Neil Howard Segal

Formats
  1. Meeting Abstract (110)
  2. Journal Article (95)
  3. Review (2)
  4. Book Section (1)
  5. Miscellaneous (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (210)
  2. Gastrointestinal Oncology Service (210)
  3. Solid Tumor Oncology Division (210)
  4. Center for Pancreatic Cancer Research (97)
  5. Surgery (80)
  6. Survivorship Research (78)

More Groups

People
  1. Leonard Saltz (81)
  2. Andrea Cercek Hanjis (68)
  3. Zsofia Stadler (67)
  4. Martin Weiser (61)
  5. Rona Yaeger (60)
  6. Jinru Shia (55)

More People

Years
  1. 2025 (6)
  2. 2024 (15)
  3. 2023 (12)
  4. 2022 (14)
  5. 2021 (11)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (78)
  2. Annals of Oncology (21)
  3. Clinical Cancer Research (9)
  4. Cancer Research (6)
  5. Journal for ImmunoTherapy of Cancer (6)
  6. Modern Pathology (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (83)
  2. Oxford University Press (26)
  3. American Association for Cancer Research (21)
  4. Elsevier Inc. (19)
  5. Nature Publishing Group (10)
  6. Biomed Central Ltd (6)

More Publishers

Results (210)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Frequency of minimal residual disease as measured by ctDNA in mismatch repair deficient tumors following curative resection
    Meeting Abstract

    Lumish, M. A.; Jayakumaran, G.; Fox, M.; Sabwa, S.; Cercek, A.; Stadler, Z. K.; Ku, G. Y.; Segal, N. H.; Won, E.; Maron, S. B.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Feasibility of organ preservation with short course radiation therapy as part of total neoadjuvant therapy in locally advanced rectal cancer during the COVID-19 pandemic
    Meeting Abstract

    Sarkar, R. R.; Wu, A. J.; Reyngold, M.; Cuaron, J. J.; Zinovoy, M.; Hajj, C.; Pappou, E.; Segal, N.; Yaeger, R.; Wei, I. H.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Frequency of minimal residual disease as measured by ctDNA in mismatch repair deficient tumors following curative resection
    Meeting Abstract

    Janjigian, Y.; Lumish, M.; Jayakumaran, G.; Fox, M.; Sabwa, S.; Cercek, A.; Stadler, Z.; Ku, G.; Segal, N.; Won, E.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Constructing hybrid control for the Morpheus metastatic colorectal cancer trial using IMblaze370 historical trial data
    Meeting Abstract

    Li, C.; Ferro, A.; Mhatre, S.; Lu, D.; Lawrance, M.; Li, S.; Allen, S.; Desai, J.; Fakih, M.; Kim, T.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Phase Ib/II open-label, randomized evaluation of efficacy and safety of atezolizumab plus isatuximab versus regorafenib in MORPHEUS-colorectal cancer
    Meeting Abstract

    Desai, J.; Fakih, M.; Pedersen, K. S.; Hong, Y. S.; Segal, N. H.; Allen, S.; Bailey, L.; Lenain, C.; Lu, D.; Sayyed, P. Z.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Phase II single-arm study of durvalumab and tremelimumab with concurrent radiotherapy in patients with mismatch repair-proficient metastatic colorectal cancer
    Journal Article

    Segal, N. H.; Cercek, A.; Ku, G.; Wu, A. J.; Rimner, A.; Khalil, D. N.; Reidy-Lagunes, D.; Cuaron, J.; Yang, T. J.; Weiser, M. R.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Clinical calculator based on molecular and clinicopathologic characteristics predicts recurrence following resection of stage I-III colon cancer
    Journal Article

    Weiser, M. R.; Hsu, M.; Bauer, P. S.; Chapman, W. C. Jr; González, I. A.; Chatterjee, D.; Lingam, D.; Mutch, M. G.; Keshinro, A.; Shia, J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Characterization and clinical outcomes of DNA mismatch repair-deficient small bowel adenocarcinoma
    Journal Article

    Latham, A.; Shia, J.; Patel, Z.; Reidy-Lagunes, D. L.; Segal, N. H.; Yaeger, R.; Ganesh, K.; Connell, L.; Kemeny, N. E.; Kelsen, D. P.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • A phase II study of induction PD-1 blockade in subjects with locally advanced mismatch repair-deficient rectal adenocarcinoma
    Meeting Abstract

    Cercek, A.; Stadler, Z. K.; Cohen, J. L.; Weiss, J. A.; Lamendola-Essel, M. F.; Krishnan, A.; Yaeger, R.; Segal, N. H.; Connell, L. C.; El Dika, I. H.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase I/II first-in-human study of a novel anti-MAGE-A4 TCR/anti-CD3 bispecific (IMC-C103C) as monotherapy and in combination with atezolizumab in HLA-A*02:01-positive patients with MAGE-A4-positive advanced solid tumors (IMC-C103C-101)
    Meeting Abstract

    Blumenschein, G. R. Jr; Davar, D.; Gutierrez, R.; Segal, N. H.; Johnson, M. L.; Dar, M. M.; Marshall, S.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save